medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2014-12-111-115medsovet-697Research ArticleАТЕРОСКЛЕРОЗ И МЕТАБОЛИЧЕСКИЙ СИНДРОМATHEROSCLEROSIS AND THE METABOLIC SYNDROMEСамоконтроль гликемии - действенная мера профилактики сердечно-сосудистых заболеваний у больных сахарным диабетомSelf-monitoring of blood glucose - an effective measure to prevent cardiovascular disease in patients with diabetesБирюковаЕ. В.BiryukovaEVnoemail@neicon.ruМосковский государственный медико-стоматологический университет им. А.И. ЕвдокимоваРоссияMoscow State University of Medicine and Dentistry named after A.I. EvdokimovRussian Federation201430122014012111115Copyright © Бирюкова Е.В., 20142014Бирюкова Е.В.Biryukova E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/697

Глобальное увеличение распространенности сахарного диабета (СД) является серьезной проблемой здравоохранения. СД - это группа метаболических заболеваний, характеризующихся гипергликемией, которая является результатом дефектов секреции инсулина, его действия или обоих этих факторов (ВОЗ, 1999). В настоящее время в мире насчитывается 382 млн людей с СД; прогнозы неутешительны: к 2035 г. эта цифра превысит 592 млн [8]. Подавляющее большинство составляют больные СД 2-го типа (СД 2). По данным Гос. Регистра в России (2013 г.) численность больных СД составила 3 млн 770 тыс., из них у 3,5 млн СД 2 [1].

The global increase in the prevalence of diabetes mellitus (DM) is a serious public health problem. DM is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both (WHO, 1999). Currently, there are 382 million people with diabetes worldwide; forecasts are disappointing: by 2035, the figure will exceed 592 million [8]. The vast majority are patients with type 2 diabetes (DM 2). According to the State Register, in Russia (2013), the number of diabetic patients was 3 million 770 thousand, of whom 3.5 million had DM 2 [1].

сахарный диабетгипергликемиягипогликемияглюкометрКонтур ТСdiabeteshyperglycemiahypoglycemiablood glucose meterContour TSReferencesАлгоритмы специализированной медицинской помощи больных сахарным диабетом. Под редакцией И.И. Дедова, М.В. Шестаковой. Вып. 6. М., 2013.Алгоритмы специализированной медицинской помощи больных сахарным диабетом. Под редакцией И.И. Дедова, М.В. Шестаковой. Вып. 6. М., 2013.Карпов Ю.А. Можно ли успешно лечить больных ишемической болезнью сердца в сочетании с сахарным диабетом. Сахарный диабет, 2002, 4: 24-28.Карпов Ю.А. Можно ли успешно лечить больных ишемической болезнью сердца в сочетании с сахарным диабетом. Сахарный диабет, 2002, 4: 24-28.Кисляк О.А., Мышляева Т.О., Малышева Н.В. Сахарный диабет 2 типа, артериальная гипертензия и риск сердечно-сосудистых осложнений. Сахарный диабет, 2008, 1 (38): 45-49.Кисляк О.А., Мышляева Т.О., Малышева Н.В. Сахарный диабет 2 типа, артериальная гипертензия и риск сердечно-сосудистых осложнений. Сахарный диабет, 2008, 1 (38): 45-49.Майоров А.Ю. Самоконтроль метаболических параметров у больных сахарным диабетом на современном этапе. Фарматека, 2006, 17: 69-84.Майоров А.Ю. Самоконтроль метаболических параметров у больных сахарным диабетом на современном этапе. Фарматека, 2006, 17: 69-84.Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Самоконтроль гликемии - неотъемлемый компонент лечения сахарного диабета. Медицинский совет, 2013, 1: 90-97.Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Самоконтроль гликемии - неотъемлемый компонент лечения сахарного диабета. Медицинский совет, 2013, 1: 90-97.Bartnik M, Ryden L, Ferrari R et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J, 2004, 25 (21): 1880-90.Bartnik M, Ryden L, Ferrari R et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J, 2004, 25 (21): 1880-90.Blonde L, Karter AJ. Current evidence regarding the value of self monitored blood glucose testing. Am J Med,, 2005, 118 (Suppl. 9A): 20S-6S.Blonde L, Karter AJ. Current evidence regarding the value of self monitored blood glucose testing. Am J Med,, 2005, 118 (Suppl. 9A): 20S-6S.Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus- present and future perspectives. Nat Rev Endocrinol, 2012, 8: 228-236.Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus- present and future perspectives. Nat Rev Endocrinol, 2012, 8: 228-236.Davidson MB, Castellanos M, Kain D et al. The effect of self monitoring of blood glucose concentrations on gly-cated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med,, 2005, 118: 422-425.Davidson MB, Castellanos M, Kain D et al. The effect of self monitoring of blood glucose concentrations on gly-cated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med,, 2005, 118: 422-425.Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care, 2010, 33 (6): 1389-1394.Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care, 2010, 33 (6): 1389-1394.Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ, 2007, 335: 13-18.Farmer A, Wade A, Goyder E et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ, 2007, 335: 13-18.Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med, 2008, 3, 58: 2545-59.Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med, 2008, 3, 58: 2545-59.Hansen MV, Pedersen-Bjergaard U, Heller SR et al. Frequency and motieves of blood glucose self-monitoring in type 1 diabetes: association with glycaemic control, complications, and patient characteristics. Diabetes Res Clin Pract, 2009, 85: 183-8.Hansen MV, Pedersen-Bjergaard U, Heller SR et al. Frequency and motieves of blood glucose self-monitoring in type 1 diabetes: association with glycaemic control, complications, and patient characteristics. Diabetes Res Clin Pract, 2009, 85: 183-8.Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008, 359: 1577-89.Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008, 359: 1577-89.International Organization for Standardization. In vitro diagnostic test systems. Requirements for blood-glucose monitoring system for self-testing in managing diabetes mellitus. Reference number ISO 15197:2003 (E). Geneva: International Organization for Standardization; 2003.International Organization for Standardization. In vitro diagnostic test systems. Requirements for blood-glucose monitoring system for self-testing in managing diabetes mellitus. Reference number ISO 15197:2003 (E). Geneva: International Organization for Standardization; 2003.Koro CE, Bowlin SJ, Bourgeois N et al. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care, 2004, 27: 17-20.Koro CE, Bowlin SJ, Bourgeois N et al. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care, 2004, 27: 17-20.Khaled AA, Sekaran M, Ikram SI. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomedical Research, 2010, 21 (2): 147-150.Khaled AA, Sekaran M, Ikram SI. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomedical Research, 2010, 21 (2): 147-150.Kuo CY, Hsu CT, Ho CS et al. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther,, 2011, 13: 596-600.Kuo CY, Hsu CT, Ho CS et al. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther,, 2011, 13: 596-600.Larsen J, Brekke M, Sandvik L et al. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes, 2002, 51: 2637-41.Larsen J, Brekke M, Sandvik L et al. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes, 2002, 51: 2637-41.Mancia G. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction. Acta Diabetol,, 2005, 42: 17-S25.Mancia G. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction. Acta Diabetol,, 2005, 42: 17-S25.McGeoch G, Derry S, Moore RA. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev., 2007, 23: 423-440.McGeoch G, Derry S, Moore RA. Self-monitoringof blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev., 2007, 23: 423-440.Mukamal KJ, Nesto RW, Cohen MC et al. Comparability of risk with prior myocardial infarction. Diabetes Care, 2001, 24 (8):1422-1427.Mukamal KJ, Nesto RW, Cohen MC et al. Comparability of risk with prior myocardial infarction. Diabetes Care, 2001, 24 (8):1422-1427.

The authors declare that there are no conflicts of interest present.